Relapsing Polychondritis

Also known as: Polychondritis, Relapsing / Polychondritis / Systemic chondromalacia / Chronic atrophic polychondritis

DrugDrug NameDrug Description
DB00250DapsoneA sulfone active against a wide range of bacteria but mainly employed for its actions against mycobacterium leprae. Its mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with pyrimethamine in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
DB00860PrednisoloneA glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
DB00635PrednisoneA synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
DrugDrug NamePhaseStatusCount
DB01281Abatacept1Completed1
DB14865Human interleukin-22Not Yet Recruiting1
DB06273Tocilizumab2Withdrawn1
DB06273TocilizumabNot AvailableCompleted1